ASH 2018 - Michael Pfeilstöckler

Michael Pfeilstöckler, MD
Hanusch Hospital Vienna, Austria

 

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

https://ash.confex.com/ash/2018/webprogram/Paper111134.html

 

0119REV1100610
×

Ask Speakers

×

Medical Information Request